Stock 8279 SYNGEN BIOTECH CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Syngen Biotech Co.,Ltd.

Equities

8279

TW0008279001

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
158 TWD -1.25% Intraday chart for Syngen Biotech Co.,Ltd. +0.64% +3.95%
13/05 Syngen Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
06/03 Syngen Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Company’s products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Microbial Pharmaceutical Raw Materials, Biological Pesticides, Fertilizers and Biochemical Nutrition Products, and Preventive Medicine
100.0 %
1,931 100.0 % 1,837 100.0 % -4.84%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
92.5 %
1,770 91.7 % 1,699 92.5 % -3.97%
Other
6.1 %
89 4.6 % 113 6.1 % +27.47%
China
1.4 %
73 3.8 % 25 1.4 % -65.53%

Managers

Managers TitleAgeSince
Wei Jen Chen CEO
 Chief Executive Officer - 01/05/01
Tzu Hui Wang DFI
 Director of Finance/CFO - -
San Ho Tsai ADM
 Chief Administrative Officer - 01/13/01
Ching Min Tsai CTO
 Chief Tech/Sci/R&D Officer - 07/12/07
Wu Jie Zun IRC
 Investor Relations Contact - -
Ming Shu Lin SAM
 Sales & Marketing - 01/13/01
Jung Tsung Huang SAM
 Sales & Marketing - 01/13/01
Fang Yuan Chu SAM
 Sales & Marketing - 18/02/18

Members of the board

Members of the board TitleAgeSince
Chin Tsai Fan BRD
 Director/Board Member - 28/99/28
Tzu Ting Fan BRD
 Director/Board Member - 29/07/29
Wu Hsiung Chuang BRD
 Director/Board Member - 19/16/19
Wei Jen Chen CEO
 Chief Executive Officer - 01/05/01
A Ching Tu BRD
 Director/Board Member - 19/14/19
Shih Chieh Li BRD
 Director/Board Member - 19/14/19
Sheng Shih Wang BRD
 Director/Board Member - 19/14/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,101,000 9,234,851 ( 34.08 %) 0 34.08 %

Shareholders

NameEquities%Valuation
First Securities Investment Trust Co. Ltd.
0.1070 %
29,000 0.1070 % 137 865 NT$

Company contact information

Syngen Biotech Co., Ltd.

Building A, No. 154 Kaiyuan Road Sinying District

730 55, Tainan

+

http://www.syngen.com.tw
address Syngen Biotech Co.,Ltd.(8279)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
158 TWD
Average target price
170 TWD
Spread / Average Target
+7.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SYNGEN BIOTECH CO.,LTD. Stock Syngen Biotech Co.,Ltd.
+3.95% 13Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.95% 81TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.62% 64TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.98% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.08% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+9.05% 30TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.30% 25TCr
ROCHE HOLDING AG Stock Roche Holding AG
+2.41% 22TCr
NOVARTIS AG Stock Novartis AG
+12.47% 22TCr
AMGEN INC. Stock Amgen Inc.
+8.91% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 8279 Stock
  4. Company Syngen Biotech Co.,Ltd.